These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Identification of the substrate binding region of vesicular monoamine transporter-2 (VMAT-2) using iodoaminoflisopolol as a novel photoprobe. Gopalakrishnan A; Sievert M; Ruoho AE Mol Pharmacol; 2007 Dec; 72(6):1567-75. PubMed ID: 17766642 [TBL] [Abstract][Full Text] [Related]
24. Dopamine transporter and vesicular monoamine transporter knockout mice : implications for Parkinson's disease. Miller GW; Wang YM; Gainetdinov RR; Caron MG Methods Mol Med; 2001; 62():179-90. PubMed ID: 21318776 [TBL] [Abstract][Full Text] [Related]
25. Vesicular monoamine transporter 2: role as a novel target for drug development. Zheng G; Dwoskin LP; Crooks PA AAPS J; 2006 Nov; 8(4):E682-92. PubMed ID: 17233532 [TBL] [Abstract][Full Text] [Related]
26. Directed evolution reveals hidden properties of VMAT, a neurotransmitter transporter. Gros Y; Schuldiner S J Biol Chem; 2010 Feb; 285(7):5076-84. PubMed ID: 20007701 [TBL] [Abstract][Full Text] [Related]
27. VMAT2 Inhibitors and the Path to Ingrezza (Valbenazine). Harriott ND; Williams JP; Smith EB; Bozigian HP; Grigoriadis DE Prog Med Chem; 2018; 57(1):87-111. PubMed ID: 29680151 [TBL] [Abstract][Full Text] [Related]
28. Role of vesicular monoamine transporter type 2 in rodent insulin secretion and glucose metabolism revealed by its specific antagonist tetrabenazine. Raffo A; Hancock K; Polito T; Xie Y; Andan G; Witkowski P; Hardy M; Barba P; Ferrara C; Maffei A; Freeby M; Goland R; Leibel RL; Sweet IR; Harris PE J Endocrinol; 2008 Jul; 198(1):41-9. PubMed ID: 18577569 [TBL] [Abstract][Full Text] [Related]
29. Mutagenesis and derivatization of human vesicle monoamine transporter 2 (VMAT2) cysteines identifies transporter domains involved in tetrabenazine binding and substrate transport. Thiriot DS; Ruoho AE J Biol Chem; 2001 Jul; 276(29):27304-15. PubMed ID: 11375404 [TBL] [Abstract][Full Text] [Related]
30. Species-specific vesicular monoamine transporter 2 (VMAT2) expression in mammalian pancreatic beta cells: implications for optimising radioligand-based human beta cell mass (BCM) imaging in animal models. Schäfer MK; Hartwig NR; Kalmbach N; Klietz M; Anlauf M; Eiden LE; Weihe E Diabetologia; 2013 May; 56(5):1047-56. PubMed ID: 23404442 [TBL] [Abstract][Full Text] [Related]
31. Presynaptic control of striatal dopamine neurotransmission in adult vesicular monoamine transporter 2 (VMAT2) mutant mice. Patel J; Mooslehner KA; Chan PM; Emson PC; Stamford JA J Neurochem; 2003 May; 85(4):898-910. PubMed ID: 12716422 [TBL] [Abstract][Full Text] [Related]
32. GZ-793A, a lobelane analog, interacts with the vesicular monoamine transporter-2 to inhibit the effect of methamphetamine. Horton DB; Nickell JR; Zheng G; Crooks PA; Dwoskin LP J Neurochem; 2013 Oct; 127(2):177-86. PubMed ID: 23875622 [TBL] [Abstract][Full Text] [Related]
34. Differences in Dihydrotetrabenazine Isomer Concentrations Following Administration of Tetrabenazine and Valbenazine. Skor H; Smith EB; Loewen G; O'Brien CF; Grigoriadis DE; Bozigian H Drugs R D; 2017 Sep; 17(3):449-459. PubMed ID: 28776237 [TBL] [Abstract][Full Text] [Related]
35. The vesicular monoamine transporter (VMAT-2) inhibitor tetrabenazine induces tremulous jaw movements in rodents: implications for pharmacological models of parkinsonian tremor. Podurgiel SJ; Nunes EJ; Yohn SE; Barber J; Thompson A; Milligan M; Lee CA; López-Cruz L; Pardo M; Valverde O; Lendent C; Baqi Y; Müller CE; Correa M; Salamone JD Neuroscience; 2013 Oct; 250():507-19. PubMed ID: 23867769 [TBL] [Abstract][Full Text] [Related]
36. Selective Knockout of the König N; Bimpisidis Z; Dumas S; Wallén-Mackenzie Å Front Behav Neurosci; 2020; 14():578443. PubMed ID: 33240055 [TBL] [Abstract][Full Text] [Related]
37. The molecular chaperone Hsc70 interacts with the vesicular monoamine transporter-2. Requena DF; Parra LA; Baust TB; Quiroz M; Leak RK; Garcia-Olivares J; Torres GE J Neurochem; 2009 Jul; 110(2):581-94. PubMed ID: 19457116 [TBL] [Abstract][Full Text] [Related]
38. Chimeric vesicular monoamine transporters identify structural domains that influence substrate affinity and sensitivity to tetrabenazine. Peter D; Vu T; Edwards RH J Biol Chem; 1996 Feb; 271(6):2979-86. PubMed ID: 8621690 [TBL] [Abstract][Full Text] [Related]